► show options
Davies Collison Cave boasts an industry leading team that head professional bodies, provide high-level government advice and have proven records as respected advocates.
Why it matters »
Sign up for our quarterly IP Update e-Mag and keep on top of the latest IP news and cases.
Subscribe now »
Read the lastest issue »
0 people found. You can filter these results or start your search again.
Close | Reset
MAY 16 | The Federal Court has upheld the validity of Eli Lilly’s Australian patent covering anti-psychotic drug olanzapine in a recent revocation … more
MAY 13 | In considering a request for an interlocutory injunction, the High Court of New Zealand found that use of the term “intercity” as a … more
More legal briefings
MAY 16 | Davies Collison Cave and AusBiotech continued to build on the success of the University Leader Speaker Series by welcoming faculty leaders from the … more
MAY 3 | Davies Collison Cave is excited to support the latest initiative of the Royal Australian Chemical Institute - the new Food Nutrition and Analytical … more
More DCC news